Citation Tools

Download PDFPDF

442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer
Free

Download to a citation manager

Cite this article as:
Wong A, Riley M, Zhao S, et al
442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer